TVAX Immunotherapy is a new approach to the treatment of cancer offering the promise of improved clinical outcomes and reduced side effects.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free